FDA approves new osteoporosis drug

The Food and Drug Administration on April 28 approved Radius Health's drug Tymlos.

The drug is used to treat osteoporosis in postmenopausal women at high risk of a fracture or who have not responded to similar therapies.

Tymlos, an intravenous drug, carries a box warning over the risk of bone cancer.

More articles on supply chain:

FDA approves RFID device to locate breast lumps
9 strategies to lower drug costs, as ranked by public support
Poll: GOP prioritizes lower drug prices over reducing government's role in healthcare

 

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Whitepapers

Featured Webinars